top of page

Cancer Research Summit

The Cancer Research Summit is a global event that brings together leading scientists, oncologists, researchers, and healthcare professionals dedicated to understanding and combating cancer. This summit will highlight the latest breakthroughs in cancer treatment, including immunotherapy, personalized medicine, early detection techniques, and emerging therapies for treatment-resistant cancers.

  • Dates: December 5–9, 2027

  • Location: Oxford, United Kingdom

  • Audience: Oncologists, cancer researchers, clinical trial coordinators, healthcare professionals, and medical practitioners in oncology.

1.jpg

Key Topics

1. Immunotherapy in Cancer Treatment: Harnessing the Immune System

Overview:
Immunotherapy is a revolutionary approach in cancer treatment that leverages the body’s immune system to fight cancer cells. This topic will cover the latest advancements in immunotherapy, including immune checkpoint inhibitors, CAR T-cell therapies, and cancer vaccines.

Key Discussion Points:

  • Immune Checkpoint Inhibitors: Recent developments in PD-1 and CTLA-4 inhibitors that enhance the immune response against cancer cells.

  • CAR T-cell Therapy: How genetically modifying T-cells can lead to more effective targeting and destruction of cancer cells.

  • Cancer Vaccines: Advances in preventive and therapeutic cancer vaccines aimed at bolstering the immune system to fight cancer.

  • Combating Immunotherapy Resistance: Strategies to overcome cancer cells' resistance to immunotherapy, enhancing treatment efficacy.

  • Personalized Immunotherapy: Tailoring immunotherapy to individual genetic profiles for improved outcomes in cancer treatment.

 
2. Personalized Medicine: Tailoring Cancer Treatment

Overview:
Personalized medicine allows for individualized treatment plans based on a patient’s genetic makeup and tumor characteristics. This session will explore how genomic profiling and precision medicine are transforming cancer care.

Key Discussion Points:

  • Genomic Profiling: How identifying specific genetic mutations in tumors can lead to targeted therapies that are more effective and less toxic.

  • Tailored Drug Therapies: Exploring drugs designed for specific genetic mutations such as EGFR, HER2, and BRCA mutations in various cancers.

  • Biomarkers in Cancer: The role of biomarkers in predicting treatment response and disease progression.

  • Challenges in Personalized Medicine: Addressing the barriers to widespread implementation of personalized treatments, including cost and access.

  • Case Studies: Successful applications of personalized medicine in treating lung, breast, and colorectal cancers.

 
3. Early Detection and Diagnostics: Catching Cancer Sooner

Overview:
Early detection of cancer is critical for improving survival rates. This topic will discuss breakthroughs in early detection technologies, including liquid biopsies, molecular imaging, and advanced screening methods.

Key Discussion Points:

  • Liquid Biopsies: The use of blood tests to detect circulating tumor DNA (ctDNA) and monitor cancer progression.

  • Molecular Imaging: Advances in imaging techniques such as PET, MRI, and CT that allow for more precise tumor visualization.

  • Screening Programs: The effectiveness of population-wide screening programs for early detection of cancers such as breast, colon, and lung cancer.

  • AI in Diagnostics: How artificial intelligence is improving the accuracy and speed of cancer diagnosis.

  • Challenges in Early Detection: Addressing false positives and false negatives, as well as ensuring equitable access to screening tools.

 
4. Overcoming Drug Resistance: New Approaches to Treatment-Resistant Cancers

Overview:
Drug resistance remains one of the biggest challenges in cancer treatment. This session will explore new approaches to overcoming resistance to chemotherapy, targeted therapies, and immunotherapies.

Key Discussion Points:

  • Mechanisms of Resistance: Understanding the biological mechanisms that allow cancer cells to develop resistance to drugs.

  • Combination Therapies: The use of multi-drug regimens and combining different treatment modalities to overcome resistance.

  • New Drug Development: Cutting-edge drugs designed to target resistance pathways in cancers like melanoma, breast, and lung cancers.

  • Clinical Trials: The latest clinical trials exploring innovative treatments for drug-resistant cancers.

  • Patient Case Studies: Real-world examples of overcoming drug resistance through personalized and combination therapies.

 
5. Cancer Genomics: Decoding the Genetic Basis of Cancer

Overview:
Cancer genomics is revolutionizing how we understand the genetic mutations that drive cancer development. This topic will focus on how genetic research is leading to new treatment options and personalized care.

Key Discussion Points:

  • Genetic Mutations in Cancer: Understanding the role of oncogenes and tumor suppressor genes in cancer initiation and progression.

  • Next-Generation Sequencing (NGS): How NGS technologies are enabling comprehensive cancer genome profiling.

  • Gene Editing in Cancer Research: The potential of CRISPR and other gene-editing technologies in developing new cancer treatments.

  • Inherited Cancer Risk: Genetic counseling and testing for hereditary cancer syndromes such as BRCA1/2 in breast cancer.

  • Translating Genomics to the Clinic: How genomic data is being integrated into clinical practice to inform treatment decisions.

 
6. Stem Cell Therapy in Cancer Treatment: A New Frontier

Overview:
Stem cell research is opening new possibilities for treating cancer, particularly for regenerating damaged tissue and targeting cancer at its root. This theme will explore the latest in stem cell therapy for cancer.

Key Discussion Points:

  • Hematopoietic Stem Cell Transplantation: Advances in bone marrow and stem cell transplants for treating blood cancers such as leukemia and lymphoma.

  • Cancer Stem Cells: How targeting cancer stem cells can prevent recurrence and metastasis in solid tumors.

  • Regenerative Medicine: The role of stem cells in repairing damage caused by cancer treatment, such as radiation and chemotherapy.

  • Stem Cell Clinical Trials: Latest developments in clinical trials exploring stem cell-based therapies for cancer patients.

  • Ethical Considerations: Addressing the ethical challenges surrounding stem cell research and its application in oncology.

 
7. Palliative Care and Cancer: Enhancing Quality of Life

Overview:
Palliative care is essential in improving the quality of life for cancer patients, especially those with advanced or terminal disease. This session will cover the latest approaches in palliative care for managing symptoms and providing psychological support.

Key Discussion Points:

  • Pain Management: New approaches to managing cancer-related pain through medication, radiation therapy, and alternative therapies.

  • Psychosocial Support: The importance of mental health care and counseling for patients undergoing cancer treatment.

  • End-of-Life Care: Best practices for providing compassionate and effective care to terminal cancer patients.

  • Integrative Therapies: The use of complementary therapies such as acupuncture, massage, and mindfulness to improve patient comfort.

  • Family and Caregiver Support: Supporting families and caregivers as they navigate the challenges of caring for cancer patients.

 Featured Speakers

11.1.jpeg

Dr. Michael Turner

Stanford University
Expertise: Cancer Genomics and Precision Medicine
Dr. Michael Turner is a renowned cancer researcher known for his contributions to understanding the genetic basis of cancer and its applications in personalized medicine.

  • Key Contributions:

    • Pioneered research into how genomic profiling can be used to tailor cancer treatments for individual patients.

    • Published breakthrough studies on the genetic mutations driving cancer growth, particularly in breast and lung cancers.

    • Led clinical trials testing the efficacy of precision medicine in improving patient outcomes for various cancers.

11.2.jpeg

Professor Sarah Lee

University of Oxford
Expertise: Immunotherapy and Cancer Vaccines
Professor Sarah Lee has made significant contributions to the field of immunotherapy, focusing on developing cancer vaccines and treatments that harness the immune system.

  • Key Contributions:

    • Developed new cancer vaccines aimed at preventing tumor growth and enhancing immune system response.

    • Led several successful clinical trials exploring the use of immune checkpoint inhibitors in treating advanced cancers.

    • Published widely on the role of immunotherapy in improving long-term survival rates in cancer patients.

11.3.jpeg

Dr. James Patterson

Mayo Clinic
Expertise: Pulmonology and COPD Management
Dr. James Patterson is a pulmonologist recognized for his work in managing chronic obstructive pulmonary disease (COPD) and developing innovative therapies to improve patient outcomes.

  • Key Contributions:

    • Pioneered the development of advanced pulmonary rehabilitation programs, significantly reducing hospital admissions for COPD patients.

    • Led research into non-invasive ventilation techniques and their role in managing acute exacerbations of COPD.

    • Published extensively on the benefits of telemedicine and remote monitoring for chronic respiratory conditions.

Program Overview

Day 1 – December 5, 2027 | Innovations in Cancer Research

  • 9:00 AM – 10:30 AM | Keynote Address: Immunotherapy – Current Trends and Future Directions

    • Speaker: Dr. Sarah Lee, University of Oxford

    • Dr. Lee will provide an in-depth look at the latest advancements in cancer immunotherapy and how it’s transforming cancer treatment across various types of tumors.

  • 10:45 AM – 12:00 PM | Panel Discussion: Genomics and Personalized Medicine

    • Moderator: Dr. Michael Turner, Stanford University

    • Panelists: Experts will explore how genetic profiling and precision medicine are shaping the future of cancer care, providing individualized treatments for patients.

  • 12:00 PM – 1:00 PM | Lunch Break

  • 1:15 PM – 2:30 PM | Workshop: Biomarkers in Cancer Diagnosis

    • Facilitator: Dr. Emily Roberts, University of British Columbia

    • Attendees will learn how biomarkers are used in early detection and treatment decision-making for various cancers.

  • 2:45 PM – 4:00 PM | Breakout Sessions

    • Session 1: Targeted Therapies in Lung Cancer

    • Session 2: Emerging Therapies for Treatment-Resistant Cancers

 

Day 2 – December 6, 2027 | New Horizons in Cancer Treatment

  • 9:00 AM – 10:30 AM | Keynote Address: Overcoming Drug Resistance in Cancer Treatment

    • Speaker: Dr. Michael Turner, Stanford University

    • This keynote will cover the challenges of drug resistance in cancer and new approaches to overcoming this critical barrier to treatment success.

  • 10:45 AM – 12:00 PM | Workshop: Cancer Vaccines and Future Possibilities

    • Facilitator: Dr. Sarah Lee, University of Oxford

    • Attendees will explore the development of cancer vaccines and their potential to revolutionize the future of cancer prevention and treatment.

  • 12:00 PM – 1:00 PM | Lunch Break

  • 1:15 PM – 2:30 PM | Panel Discussion: Genomic Research and Its Role in Cancer Treatment

    • Moderator: Dr. Michael Turner, Stanford University

    • Panelists: Experts will discuss how advancements in cancer genomics are leading to more precise and effective treatments.

  • 2:45 PM – 4:00 PM | Interactive Session: Ethical Considerations in Cancer Research

    • An interactive session discussing the ethical challenges and considerations in modern cancer research, including data privacy and clinical trial transparency.

 

Day 3 – December 7, 2027 | The Future of Cancer Research

  • 9:00 AM – 10:30 AM | Panel Discussion: The Role of AI in Cancer Diagnosis and Treatment

    • Moderator: Dr. Emily Roberts, University of British Columbia

    • Panelists: Experts will explore how artificial intelligence is being used to enhance cancer diagnosis, streamline treatment planning, and improve patient outcomes.

  • 10:45 AM – 12:00 PM | Workshop: Advances in Cancer Imaging Technologies

    • Facilitator: Dr. Anna Lee, Stanford University

    • A hands-on workshop exploring the latest imaging technologies for detecting cancer earlier and more accurately, including AI-enhanced imaging.

  • 12:00 PM – 1:00 PM | Lunch Break

  • 1:15 PM – 2:30 PM | Panel Discussion: Pediatric Oncology – Challenges and Innovations

    • Moderator: Dr. Susan White, Johns Hopkins University

    • Panelists: Pediatric oncologists will share insights on managing childhood cancers and the latest innovations in treatment options for young patients.

  • 2:45 PM – 4:00 PM | Closing Remarks: Shaping the Future of Cancer Research

    • Speaker: Dr. Sarah Lee, University of Oxford

    • Dr. Lee will provide a forward-looking view on how global collaboration and technological advancements are shaping the future of cancer research.

  • Facebook
  • Twitter
  • YouTube
  • Instagram
UKAC LOGO.jpg

Get in touch

the UK Academic Conferences

UKAC Diamond Sponsors

corroll logo.jpg
bpp Logo.jpg

© 2015 by UK Academic Conference LTD

bottom of page